Sarah E LeBoeuf

5PUBLICATIONS
51CO-AUTHORS
Tumour immunologyCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2023
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth.

Ali Rashidfarrokhi, Ray Pillai, Yuan Hao

|Jul 10, 2023
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.

Ray Pillai, Sarah E LeBoeuf, Yuan Hao

|Nov 17, 2021
Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.

Hongyu Ding, Zihong Chen, Katherine Wu

|Oct 03, 2017
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer.

Volkan I Sayin, Sarah E LeBoeuf, Simranjit X Singh

Pageof 1